CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...